Develops targeted protein degradation therapies to overcome drug resistance, with a primary focus on oncology and related diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
PineTree Therapeutics develops transformative therapies using targeted protein degradation technology to address drug resistance, primarily focusing on innovative solutions in oncology and related fields. The company aims to lead advancements in this area by leveraging its proprietary approaches to degrade disease-causing proteins.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
PineTree Therapeutics Management Team
Investors
Atinum Investment
DSC Investment, Inc.
Quantum Capital Partners
Schmidt Family Foundation
SGI Partners
S&S Investment
STIC Investments, Inc.
PineTree Therapeutics Valuations & Financials
View real-time NPM data on PineTree Therapeutics stock including daily PineTree Therapeutics stock price estimates, valuation history, and historical share price information. Access PineTree Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track PineTree Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on PineTree Therapeutics? Get in touch to learn more.
Similar Companies
like PineTree Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Firestorm
Industrials
Develops radically affordable, mission-adaptable unmanned aerial systems (UAS) using modular, open-system designs and distributed manufacturing.
MeetsMore
Commerce & Marketplaces
Online marketplace connecting customers with service professionals for moving, cleaning, and events, offering free estimates and provider comparison.
Swift Navigation
AI & Machine Learning
Provides affordable, high-precision navigation solutions for autonomous projects.
Planted
Consumer
Develops and manufactures plant-based meat alternatives that replicate traditional meat, focusing on sustainable food production and innovation.
Billee
Enterprise Software
Automates utility billing processes that provide accurate insights and streamlined management for multifamily properties.
Holberton
Consumer
Provides a project-based software engineering education platform that integrates peer-driven learning and AI-powered code reviews to train future-ready developers.
Dropzone AI
Cybersecurity
Develops autonomous AI agents that enhance cybersecurity operations by investigating alerts.
CScale
AI & Machine Learning
Delivers integrated light engines to accelerate low-latency data transmission across compute clusters.
FAQ
We have answers
PineTree Therapeutics stock does not trade on public stock exchanges. PineTree Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in PineTree Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
PineTree Therapeutics Stock does not trade on public stock exchanges. In order to sell PineTree Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
PineTree Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view PineTree Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for PineTree Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell PineTree Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in PineTree Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
PineTree Therapeutics is a private company and has not had an IPO. There is currently no PineTree Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to PineTree Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
